[1]崔　敬　佟建洲.HOXC10在人脑胶质瘤中的表达及其与病人预后的关系[J].中国临床神经外科杂志,2020,(08):513-516.[doi:10.13798/j.issn.1009-153X.2020.08.006]
　CUI Jing,TONG Jian-zhou..Expression of HOXC10 in human glioma tissue and its relationship with prognosis of patients with glioma[J].,2020,(08):513-516.[doi:10.13798/j.issn.1009-153X.2020.08.006]
点击复制

HOXC10在人脑胶质瘤中的表达及其与病人预后的关系()
分享到：

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
期数:
2020年08期
页码:
513-516
栏目:
论著
出版日期:
2020-08-25

文章信息/Info

Title:
Expression of HOXC10 in human glioma tissue and its relationship with prognosis of patients with glioma
文章编号:
1009-153X（2020）08-0513-04
作者:
崔　敬　佟建洲
071000 河北，保定市第一中心医院西院神经外二科（崔　敬、佟建洲）
Author(s):
CUI Jing;  TONG Jian-zhou.
Department of Neurosurgery, West Hospital, Baoding First Central Hospital, Hebei 071000, China
关键词:
胶质瘤; 同源框C10; HOXC10; 基因表达; 预后
Keywords:
Homeobox C10;  Glioma;  Gene expression;  Immunohistochemistry;  Prognosis
分类号:
A
DOI:
10.13798/j.issn.1009-153X.2020.08.006
文献标志码:
R 739.41; Q 786
摘要:
目的 探讨同源框C10（HOXC10）在人脑胶质瘤组织中的表达及其与病人预后的关系。方法 选取2013年6月至2018年4月手术切除的胶质瘤组织106例和2018年4月至2019年6月颅脑损伤内减压术中切除的正常脑组织30例，SP法免疫组织化学染色检测HOXC10的表达水平。Cox比例回归风险模型分析总生存期（OS）和无进展生存期（PFS）的影响因素。生存曲线分析HOXC10表达水平与OS和PFS的关系。结果 高级别胶质瘤组织HOXC10表达水平明显高于低级别胶质瘤组织（P<0.001），而低级别胶质瘤组织又明显高于正常脑组织（P<0.001）。多因素Cox比例回归风险模型分析显示，WHO分级Ⅲ~Ⅳ级、术后未化疗和HOXC10高表达是胶质瘤病人OS和PFS较短的独立影响因素（P<0.05）。HOXC10高表达组病人中位OS为38个月（四分位间距28~42个月），中位PFS为26个月（四分位间距22~45个月）；HOXC10低表达组中位OS为47个月（四分位间距36~54个月），中位PFS为48个月（四分位间距44~53个月）。HOXC10低表达组OS和PFS均明显高于高表达组（P<0.05）。结论 人脑胶质瘤组织HOXC10表达水平明显增高，与不良生存预后和肿瘤进展有关
Abstract:
Objective To explore the expression level of homeobox C10 (HOXC10) in human glioma tissues and its relationship with the prognosis of patient with glioma. Methods The expression levels of HOXC10 were detected by SP immunological staining in glioma tissues which were obtained from 106 patients with glioma underwent surgery from June 2013 to April 2018 and in normal brain tissues which were obtained from 30 patients with traumatic brain injury underwent decompression from April 2018 to June 2019. Cox proportional regression risk model was used to analyze the risk factors for overall survival (OS) and progression-free survival (PFS). The survival curve was used to analyzes the relationship between the expression level of HOXC10 and OS and PFS. Results The expression level of HOXC10 of high-grade glioma tissues was significantly higher than that of low-grade glioma tissues (P<0.001), which was significantly higher than that of normal brain tissue (P<0.001). Multivariate Cox proportional regression risk model analysis showed that WHO grade Ⅲ~Ⅳ, no postoperative chemotherapy, and high expression of HOXC10 were independent risk factors of shorter OS and PFS of glioma patients (P<0.05). The median OS of patients with high expression of HOXC10 was 38 months (interquartile, 28~42 months), and the median PFS was 26 months (interquartile, 22~45 months). The median OS of patients with low expession of HOXC10 was 47 months (interquartile, 36 to 54 months), and the median PFS was 48 months (interquartile, 44~53 months). The OS and PFS of patients with low expression of HOXC10 were significantly higher than those of patients with high expression of HOXC10 (P<0.05). Conclusion The expression level of HOXC10 in human glioma tissues is significantly increased, which is related to poor survival prognosis and tumor progression of patients with glioma

参考文献/References:

[1] Davis ME. Epidemiology and overview of gliomas [J]. Semin Oncol Nurs, 2018, 34(5): 420-429.
[2] Dang Y, Chen J, Feng W, et al. Interleukin 1β-mediated HOXC10 overexpression promotes hepatocellular carcinoma metastasis by upregulating PDPK1 and VASP [J]. Therano- stics, 2020, 10(8): 3833-3848.
[3] 冯　帆，王　帅，王亚雨，等. CUX-1在胶质瘤中的表达 及其对临床病理和预后的意义[J]. 国际神经病学神经外 科学杂志，2019，35（4）： 401-405.
[4] 张立志，刘　平，吉慧军，等. 全身炎症反应指数对胶质瘤 患者临床预后影响及与IDH1突变的关系[J]. 实用肿瘤 学杂志，2018，32（1）： 25-32.
[5] Kim J, Bae DH, Kim JH, et al. HOXC10 overexpression pro- motes cell proliferation and migration in gastric cancer [J]. Oncol Rep, 2019, 42(1): 202-212.
[6] Tang XL, Ding BX, Hua Y, et al. HOXC10 Promotes the metastasis of human lung adenocarcinoma and indicates poor survival outcome [J]. Front Physiol, 2017, 8: 557-565.
[7] Dai BW, Yang ZM, Deng P, et al. HOXC10 promotes migra- tion and invasion via the WNT-EMT signaling pathway in oral squamous cell carcinoma [J]. J Cancer, 2019, 10(19): 4540-4551.
[8] Tan Z, Chen K, Wu W, et al. Overexpression of HOXC10 promotes angiogenesis in human glioma via interaction with PRMT5 and upregulation of VEGFA expression [J]. Thera- nostics, 2018, 8(18): 5143-5158.
[9] Li S, Zhang W, Wu C, et al. HOXC10 promotes proliferation and invasion and induces immunosuppressive gene expre- ssion in glioma [J]. FEBS J, 2018, 285(12): 2278-2291.
[10] Guan Y, He Y, Lv S, et al. Overexpression of HOXC10 pro- motes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway [J]. J Drug Target, 2019, 27(1): 60-66.

相似文献/References:

[1]常英男　王　策　赵天书.SOX2基因在胶质瘤中的表达及生物学作用[J].中国临床神经外科杂志,2016,(05):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
　CHANG Ying-nan,WANG Ce,ZHAO Tian-shu..Expression of SOX2 gene and its biological role in human gliomas[J].,2016,(08):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
[2]赛　克　陈忠平.胶质瘤的疗效评价[J].中国临床神经外科杂志,2016,(06):321.[doi:10.13798/j.issn.1009-153X.2016.06.001]
[3]许　耿　路俊锋　杨　忠　施建斌　吴秋月　王　烨　庄冬晓　吴劲松.神经电生理监测技术在功能区胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(06):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
　XU Geng,LU Jun-feng,YANG Zhong,et al.Application of intraoperative neuroelectrophysiologic monitoring to gliomas resection in eloquent function brain regions[J].,2016,(08):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
[4]李剑峰　陈银生　赛　克　张湘衡　柯　超　杨群英　牟永告　许海雄　陈忠平.173例胶质瘤预后的影响因素分析[J].中国临床神经外科杂志,2016,(06):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
　LI Jian-feng,CHEN Yin-sheng,SAI Ke,et al.Prognostic factors for gliomas: analysis of 173 cases[J].,2016,(08):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
[5]云德波　杨宇焦　张　逵　范润金　张　渊　杜贻庆.瘤周谷氨酸、天门冬氨酸水平与胶质瘤继发性 癫痫的相关性[J].中国临床神经外科杂志,2016,(06):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
　YUN De-bo,YANG Yu-Jiao,ZHANG Kui,et al.Relationship of levels of glutamate and aspartate in peritumorous tissues with seizures in patients with gliomas[J].,2016,(08):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
[6]黄书岚　成于思　王　辉　汪超甲.FAK siRNA重组质粒的构建及其对胶质瘤U251细胞 增殖及侵袭能力的抑制作用[J].中国临床神经外科杂志,2016,(06):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
　HUANG Shu-lan,CHENG Yu-si,WANG Hui,et al.Construction of siRNA recombinant plasmid targeting focal adhesion kinase gene and its effect on the proliferation and invasiveness of human glioma U251cells[J].,2016,(08):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
[7]林　雨　张　恺　李　帅　杨学军.磁共振数字化手术单元在指导胶质瘤治疗中的作用[J].中国临床神经外科杂志,2016,(06):345.[doi:10.13798/j.issn.1009-153X.2016.06.009]
[8]戴黎明　徐成仕　王泽芬　曹长军　李志强.VEGF单抗对低氧环境下C6胶质瘤细胞侵袭性的影响[J].中国临床神经外科杂志,2016,(04):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
　DAI Li-ming,XU Cheng-shi,WANG Ze-fen,et al.Effect of nonoclonal antibody of VEGF on C6 glioma cells invasiveness under hypoxia and the role of FAK/Pyk2[J].,2016,(08):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
[9]彭泽生　田道锋　张申起　陈谦学.miR-370-3p对胶质母细胞瘤U87-MG细胞株增殖能力的影响[J].中国临床神经外科杂志,2016,(04):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
　PENG Ze-sheng,TIAN Dao-feng,ZHANG Shen-qi,et al.Effects of MircoRNA-370-3p on proliferation of glioma cell line U87-MG and its potential mechanism[J].,2016,(08):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
[10]冯　驰　郭双毅　程龙海　罗　杰.氯喹通过抑制自噬促进TRAIL诱导的胶质瘤细胞凋亡[J].中国临床神经外科杂志,2016,(04):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
　FENG Chi,GUO Shuang-yi,CHENG Long-hai,et al.Chloroquine promotes TRAIL-induced apoptosis of glioma cells through inhibition of autophagy[J].,2016,(08):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]

备注/Memo

备注/Memo:
（2020-04-29收稿，2020-05-22修回）通讯作者：佟建洲，E-mail：69650764@qq.com
更新日期/Last Update: 2020-08-15